Meet the Professor |
07:30-08:20, Crystall Ballroom A,B,C |
1:Role of an innovative medical oncologist in the management of cancer patients |
Hoo Geun Chun (The Catholic University of Korea College of Medicine) |
2:Minimally invasive surgery for colorectal cancer: the 2015 update on evidence |
Seon-Hahn KIM (Korea University College of Medicine) |
3:Role of surgical oncologist in gastric cancer research |
Han-Kwang Yang (Seoul National University College of Medicine) |
|
Educational Session |
08:30-09:40 |
1:Innovative treatment in medical oncology |
Crystal Ballroom A |
1) Innovative treatment of breast cancer |
Kyong Hwa Park (Korea University College of Medicine) |
2) Innovative treatment of sarcoma |
Jin Hee Ahn (Asan Medical Center) |
3) Innovative treatment of colon cancer |
Sang-Cheol Lee (Soonchunhyang University College of Medicine) |
2:Current status of brachytherapy in Korea |
Crystal Ballroom B |
1) Current status of brachytherapy for gynecologic cancer in Korea |
Yong Bae Kim (Yonsei University College of Medicine) |
2) Recent improvement of brachytherapy in cervical cancer |
Yeon-Joo Kim (National Cancer Center) |
3) Current status of prostate brachytherapy in Korea |
Jaeho Cho (Yonsei University College of Medicine) |
3:Oncologic views of radical and limited LN dissection |
Crystal Ballroom C |
1) Oncologic views of radical & limited lymph node dissection: colorectal cancer |
Jung-Myun Kwak (Korea University College of Medicine) |
2) Oncologic views of radical and limited LN dissection in breast cancer treatment |
Jeong Eon Lee (Samsung Medical Center) |
3) Determination for extent of LN dissection: Ongoing dilemma of gastric cancer surgery |
Han Hong Lee (The Catholic University of Korea College of Medicine) |
|
Young Investigator Symposium |
08:30-09:40, Sapphire Ballroom B |
1) Phase I trials as cancer therapy: clinical fellowship experience at MD Anderson Cancer Center |
Yong Wha Moon (Yonsei University College of Medicine) |
2) Role of aggressive debulking surgery in advanced ovarian cancer: Can surgical aggressiveness compensate for tumor biology? |
Suk-Joon Chang (Ajou University School of Medicine) |
3) Tumor heterogeneity in lung cancer |
Sang-Won Um (Samsung Medical Center) |
4) The methyltransferases EZH1 and EZH2 control hepatocyte homeostasis and regeneration |
Woo Kyun Bae (Chonnam National University Medical School) |
|
Plenary Lecture 1 (in English) |
10:00-10:30, Crystal Ballroom |
Dare to push the limit |
Jin Soo Lee, M.D., Ph.D. (National Cancer Center) |
|
Plenary Lecture 2 (in English) |
10:30-11:20, Crystal Ballroom |
Fundamental insights and translational opportunities arising from cancer epigenetics |
Peter W. Laird, Ph.D. (Professor and Head, Center for Epigenetics, Van Andel Research Institute, USA) |
|
Symposium 1 (in English) |
12:40-14:20, Crystal Ballroom A |
Gastric cancer |
1) Genomic landscape of gastric cancer |
Jae Yong Cho (Yonsei University College of Medicine) |
2) Recent developments of targeted therapy in gastric cancer |
Atsushi Ohtsu (National Cancer Center Hospital East, Japan) |
3) Role of adjuvant/neo-adjuvant chemotherapy in locally advanced gastric cancer |
Lin Shen (Peking University Cancer Hospital & Institute, China) |
4) The use of exhaled breath test for the diagnosis and therapeutic monitoring of gastric cancer |
George Hanna (Imperial College of London, UK) |
|
Symposium 2 (in English) |
12:40-14:20, Crystal Ballroom B |
Epigenetics and cancer therapy |
1) DNA Hypermethylome signature in human cancer for clinical use |
Joo Mi Yi (Dongnam Institute of Radiological & Medical Sciences) |
2) Identification of altered DNA methylation modulators in ovarian cancer cells with acquired cisplatin resistance |
Yoon Jung Park (Ewha Womans University College of Health Science) |
3) A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer |
Jeong Hoon Kim (Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University) |
4) Targeting chromatin remodeler for cancer radiotherapy |
Jongbum Kwon (Ewha Womans University College of Natural Sciences) |
|
Symposium 3 |
12:40-14:20, Crystal Ballroom C |
Mitochondria energy metabloism |
1) Identification of therapeutic target that links AMPK to WNT signaling in early-stage gastric cancer |
Yon Hui Sarah Kim (National Cancer Center) |
2) Mitochondrial chaperone TRAP1: structure, function, and inhibitors |
Byoung Heon Kang (Ulsan National Institute of Science and Technology) |
3) Post-transcriptional regulation of mitochondrial dynamics |
Dong-Hyung Cho (Graduate School of East-West Medical Science, Kyung Hee University) |
4) Apoptosis via mitochondria in epstein-barr virus transformed B cells |
Dae Young Hur (Inje University College of Medicine) |
|
Symposium 4 (in English) |
12:40-14:20, Sapphire Ballroom B |
Joint Symposium (Korean Cancer Association & Shanghai Cancer Institute) |
Novel strategies for anticancer therapy I |
1) New insights into cellular origin of prostate epithelial development and tumorigenesis |
Wei-Qiang Gao (Shanghai Cancer Institute, China) |
2) Experimental therapeutic strategies for targeting HCC cancer stem cells |
Jinjun Li (Shanghai Cancer Institute, China) |
3) Different function of ARD1 variants in tumorigenesis |
Kyu-Won Kim (Seoul National University College of Pharmacy) |
4) Experience of next generation sequencing analysis of Korean breast cancer |
Wonshik Han (Seoul National University College of Medicine) |
|
|
Symposium 5 |
14:40-16:20, Crystal Ballroom A |
Survivorship program and care plan |
1) Primary care provider perspectives |
Kyung Hyun Choi (Dongnam Institute of Radiological & Medical Sciences) |
2) Nursing care provider perspectives |
Soo Hyun Kim (Inha University College of Medicine) |
3) Specialty care provider perspectives |
Hye Yoon Park (Seoul National University College of Medicine) |
4) Oncologist care provider perspectives |
Dae Ho Lee (Asan Medical Center) |
|
Symposium 6 (in English) |
14:40-16:20, Crystal Ballroom B |
Joint Symposium (Korean Cancer Association & Korean Genome Organization) |
Next great leap of omics for personalized medicine in cancer |
1) An integrative proteogenomics approach in gastric cancer |
Daehee Hwang (Daegu Gyeongbuk Institute of Science & Technology) |
2) Cooperation of driver mutations induces epithelial-to-mesenchymal transition in lung cancer |
Hyun Seok Kim (Yonsei University College of Medicine) |
3) Application of cancer genome anlaysis in clinical oncology |
Yoon-La Choi (Samsung Medical Center) |
4) Epigenetic control of gene expression dynamics |
TaeSoo Kim (Ewha Womans University College of Natural Sciences) |
|
Symposium 7 (in English) |
14:40-16:20, Crystal Ballroom C |
New treatment in cancer |
1) Laparoscopic and function preserving cancer surgery : evidences in gastric cancer |
Hyuk-Joon Lee (Seoul National University College of Medicine) |
2) Review of carbon ion radiotherapy and current status of Korea Heavy-ion Medical Accelerator (KHIMA) project |
Mi Sook Kim (Korea Institute of Radiological & Medical Sciences) |
3) Targeted radionuclide therapy |
So Won Oh (Seoul National University Boramae Medical Center) |
|
Symposium 8 |
14:40-16:20, Sapphire Ballroom A |
Joint Symposium (Korean Cancer Association & Korean Society of Nuclear Medicine) |
Advence of radionuclide theranostics in oncology |
1) Radionuclide theranostics in radioiodine-refractory thyroid cancer |
Byeong-Cheol Ahn (Kyungpook National University School of Medicine) |
2) Radioembolization in hepatocellular carcinoma |
Jae-Gol Choe (Korea University College of Medicine) |
3) I-131 rituximab radioimmunotherapy in B cell lymphoma |
Sang-Moo Lim (Korea Institute of Radiological & Medical Sciences) |
|
Symposium 9 (in English) |
14:40-16:20, Sapphire Ballroom B |
Joint Symposium (Korean Cancer Association & Shanghai Cancer Institute) |
Novel strategies for anticancer therapy II |
1) Novel concept for cancer targeted therapy |
Zonghai Li (Shanghai Cancer Institute, China) |
2) Regulation of Warburg effect by hormone receptors in hepatocellular carcinoma |
Zhigang Zhang (Shanghai Cancer Institute, China) |
3) Stromal stem-like cells for maintenance of infiltrative property in human glioblastoma |
Su-Jae Lee (Hanyang University College of Natural Sciences) |
4) Hypoxia induces angiogenic miRs targeting tumour suppressors |
You Mie Lee (Kyungpook National University College of Pharmacy) |
|
Satellite Symposium 1 (in English) |
11:30-12:20, Crystal Ballroom |
A decade of anti-angiogenic therapy: past, present and future (by Roche) |
Yeul Hong Kim (Korea University College of Medicine) |
|
Satellite Symposium 2 (in English) |
11:30-12:20, Sapphire Ballroom |
Emerging role of immunotherapy (by MSD) |
Kenneth O'Byrne (Princess Alexandra Hospital, Australia) |
|
Satellite Symposium 3 (in English) |
18:00~19:00, Crystal Ballroom A |
New Treatment in ALK+ Lung Cancer (by Novartis) |
Dong-Wan Kim (Seoul National University College of Medicine) |
|
Satellite Symposium 4 (in English) |
18:00~20:00, Crystal Ballroom B |
'Bayer Korea Oncology Symposium |
I. GI cancer |
1) Colorectal Cancer-The role of targeted therapies in the strategy of mCRC treatment |
Salvatore Siena (Niguarda Ca' Granda, Milan, Italy) |
2) Gastric cancer- Revisit of antiangiogenesis strategy in gastric cancer |
Do-Youn Oh (Seoul National University College of Medicine) |
II. Cancer cell signaling and metabolism |
1) How to address new targets in oncology |
Dirk Laurent (Bayer, USA) |
2) Research experience for biomarker development in cancer treatment |
Sun Young Rha (Yonsei University College of Medicine) |
|
Oral Presentation 1 |
12:40-13:30, Sapphire Ballroom A |
|
Oral Presentation 2 |
13:30-14:20, Sapphire Ballroom A |
|
Oral Presentation 3 |
16:20-17:40, Crystall Ballroom A |
|
Oral Presentation 4 |
16:20-17:40, Crystall Ballroom B |
|
Oral Presentation 5 |
16:20-17:40, Crystall Ballroom C |
|
International Session 1 (Oral, in English) |
16:20-17:40, Sapphire Ballroom A |
|
International Session 2 (Oral, in English) |
16:20-17:40, Sapphire Ballroom B |
|
Poster Presentation |
09:00~17:00, Emerald Room |
|